David Leah is Director of Business Development at Certara. With over 12 years’ experience in the life sciences sector across EMEA and APAC, his career includes commercial roles supporting emerging biotechs to global pharmaceutical companies in bringing innovative, breakthrough treatments to patients.
Dave has proven expertise across multiple therapeutic areas, including oncology and rare diseases, and a good understanding of diverse treatment modalities such as cell and gene therapies and is well-versed in the unique challenges faced by smaller and early-stage biotechs, with experience supporting tier 3 programmes from discovery through to marketing authorisation.
